2024-10-01 2026-02-28 2026-02-28 false 14329517 Hype Tattoo & Piercing Studio Limited 96090Other service activities not elsewhere classified iso4217:GBP xbrli:pure 143295172024-10-01 143295172026-02-28 143295172024-10-01 2026-02-28 14329517bus:SmallEntities2024-10-01 2026-02-28 14329517bus:AuditExempt-NoAccountantsReport2024-10-01 2026-02-28 14329517bus:FullAccounts2024-10-01 2026-02-28 14329517core:WithinOneYear2026-02-28 14329517core:AfterOneYear2026-02-28 14329517core:WithinOneYear2024-10-01 2026-02-28 14329517core:AfterOneYear2024-10-01 2026-02-28 14329517core:CurrentFinancialInstruments2026-02-28 14329517core:Non-currentFinancialInstruments2026-02-28 14329517core:CurrentFinancialInstruments2024-10-01 2026-02-28 14329517core:Non-currentFinancialInstruments2024-10-01 2026-02-28 14329517core:LandBuildings2024-10-01 2026-02-28 14329517core:FurnitureFittings2024-10-01 2026-02-28 14329517core:OfficeEquipment2024-10-01 2026-02-28 14329517core:Vehicles2024-10-01 2026-02-28 14329517core:PlantMachinery2024-10-01 2026-02-28 14329517core:OtherPropertyPlantEquipment2024-10-01 2026-02-28 14329517core:LandBuildings2026-02-28 14329517core:PlantMachinery2026-02-28 14329517core:Vehicles2026-02-28 14329517core:FurnitureFittings2026-02-28 14329517core:OfficeEquipment2026-02-28 14329517core:OtherPropertyPlantEquipment2026-02-28 14329517core:Right-of-useAssets2024-10-01 2026-02-28 14329517core:Right-of-useAssets2026-02-28 14329517core:Goodwill2024-10-01 2026-02-28 14329517core:PatentsTrademarksLicencesConcessionsSimilar2024-10-01 2026-02-28 14329517core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-10-01 2026-02-28 14329517core:OtherResidualIntangibleAssets2024-10-01 2026-02-28 14329517core:Goodwill2026-02-28 14329517core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-02-28 14329517core:PatentsTrademarksLicencesConcessionsSimilar2026-02-28 14329517core:OtherResidualIntangibleAssets2026-02-28 14329517dpl:CostSales2024-10-01 2026-02-28 14329517dpl:AdministrativeExpenses2024-10-01 2026-02-28 14329517dpl:DistributionCosts2024-10-01 2026-02-2814329517core:ShareCapital2026-02-28 14329517core:SharePremium2026-02-28 14329517core:RevaluationReserve2026-02-28 14329517core:OtherReservesSubtotal2026-02-28 14329517core:ShareCapitalPreferenceShares2026-02-28 14329517core:CapitalRedemptionReserve2026-02-28 14329517core:OtherCapitalReserve2026-02-28 14329517core:RetainedEarningsAccumulatedLosses2026-02-2814329517core:ShareCapital2024-10-01 2026-02-28 14329517core:SharePremium2024-10-01 2026-02-28 14329517core:RevaluationReserve2024-10-01 2026-02-28 14329517core:OtherReservesSubtotal2024-10-01 2026-02-28 14329517core:RetainedEarningsAccumulatedLosses2024-10-01 2026-02-281432951712024-10-01 2026-02-28 1432951722024-10-01 2026-02-2814329517core:ShareCapital12024-10-01 2026-02-28 14329517core:ShareCapital22024-10-01 2026-02-2814329517core:SharePremium12024-10-01 2026-02-28 14329517core:SharePremium22024-10-01 2026-02-2814329517core:RevaluationReserve12024-10-01 2026-02-28 14329517core:RevaluationReserve22024-10-01 2026-02-2814329517core:RetainedEarningsAccumulatedLosses12024-10-01 2026-02-28 14329517core:RetainedEarningsAccumulatedLosses22024-10-01 2026-02-281432951712024-10-01 2026-02-2814329517core:Non-currentFinancialInstrumentscore:CostValuation2024-10-01 14329517core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:CostValuation2026-02-2814329517core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2024-10-01 14329517core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-02-28 14329517core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-02-28 14329517core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-02-2814329517core:Non-currentFinancialInstruments2026-02-28 14329517core:Non-currentFinancialInstruments2024-09-30143295172023-10-01 143295172024-09-30 143295172023-10-01 2024-09-30 14329517core:WithinOneYear2024-09-30 14329517core:AfterOneYear2024-09-30 14329517core:CurrentFinancialInstruments2024-09-30 14329517core:Non-currentFinancialInstruments2024-09-30 14329517core:LandBuildings2024-09-30 14329517core:PlantMachinery2024-09-30 14329517core:Vehicles2024-09-30 14329517core:FurnitureFittings2024-09-30 14329517core:OfficeEquipment2024-09-30 14329517core:OtherPropertyPlantEquipment2024-09-30 14329517core:Right-of-useAssets2024-09-30 14329517core:Goodwill2024-09-30 14329517core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-09-30 14329517core:PatentsTrademarksLicencesConcessionsSimilar2024-09-30 14329517core:OtherResidualIntangibleAssets2024-09-30 14329517dpl:AdministrativeExpenses2023-10-01 2024-09-3014329517core:ShareCapital2024-09-30 14329517core:SharePremium2024-09-30 14329517core:RevaluationReserve2024-09-30 14329517core:OtherReservesSubtotal2024-09-30 14329517core:ShareCapitalPreferenceShares2024-09-30 14329517core:CapitalRedemptionReserve2024-09-30 14329517core:OtherCapitalReserve2024-09-30 14329517core:RetainedEarningsAccumulatedLosses2024-09-3014329517core:RetainedEarningsAccumulatedLosses2023-10-01 14329517core:ShareCapital2023-10-01 14329517core:SharePremium2023-10-01 14329517core:RevaluationReserve2023-10-01 14329517core:ShareCapital2023-10-01 2024-09-30 14329517core:SharePremium2023-10-01 2024-09-30 14329517core:RevaluationReserve2023-10-01 2024-09-30 14329517core:OtherReservesSubtotal2023-10-01 2024-09-30 14329517core:RetainedEarningsAccumulatedLosses2023-10-01 2024-09-301432951712023-10-01 2024-09-30 1432951722023-10-01 2024-09-3014329517core:ShareCapital12023-10-01 2024-09-30 14329517core:ShareCapital22023-10-01 2024-09-3014329517core:SharePremium12023-10-01 2024-09-30 14329517core:SharePremium22023-10-01 2024-09-3014329517core:RevaluationReserve12023-10-01 2024-09-30 14329517core:RevaluationReserve22023-10-01 2024-09-3014329517core:RetainedEarningsAccumulatedLosses12023-10-01 2024-09-30 14329517core:RetainedEarningsAccumulatedLosses22023-10-01 2024-09-3014329517bus:Director12024-10-01 2026-02-2814329517bus:PrivateLimitedCompanyLtd2024-10-01 2026-02-28
Hype Tattoo & Piercing Studio Limited
Unaudited Financial Statements
for the period ended 28 February 2026
Company registration number 14329517
(England and Wales)

Company Information

For the period 1 October 2024 to 28 February 2026
Director Summers, John Archbold

Registered office 3 Berrymoor Court
Northumberland Business Park
Cramlington
NE23 7RZ

Registered number 14329517

Accountant AWS Accountancy Ltd
3 Berrymoor Court
Cramlington
Northumberland
NE23 7RZ

Statement of Financial Position

As at 28 February 2026
Notes
28 Feb 2026
30 Sep 2024
£
£
£
£
Fixed assets
Tangible assets
4
-
9,546
-
9,546
Current assets
Stocks
5
-
1,011
Debtors
6
8,660
6,729
Cash at bank and in hand
511
3,261
9,171
11,001
Creditors
Amounts falling due within one year
7
(4,308)
(2,548)
(4,308)
(2,548)
Net current assets (liabilities)
4,863
8,453
Total assets less current liabilities
4,863
17,999
Net assets (liabilities)
4,863
17,999
Capital and reserves
Called up share capital
9
1
1
Profit and loss account
4,862
17,998
Total equity
4,863
17,999

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the director on 16 September 2026 and are signed on its behalf by:

Summers, John Archbold
Summers, John Archbold
Director

Company registration number 14329517

Notes to the Financial Statements

For the period 1 October 2024 to 28 February 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.



2.3. Pensions

Defined contribution pension plan

The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.

2.4. Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Rate
Method
%
Fixtures and fittings
15
Reducing balance

2.5. Stocks and work in progress

Inventories are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method. The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, inventories are assessed for impairment. If an item of inventory is impaired, the carrying amount is reduced to its selling price less costs to complete and sell, and the impairment loss is recognised immediately in the income statement. When inventories are sold, the carrying amount is recognised as an expense in the period in which the related revenue is recognised.


3. Employees

The average number of employees during the year was 2 (2024: 2).

4. Tangible fixed assets

Fixtures and fittings
Total
£
£
Cost
At 1 October 2024
13,113
13,113
Disposals
(13,113)
(13,113)
At 28 February 2026
-
-
Depreciation and impairment
At 1 October 2024
3,567
3,567
Charge for the period
2,029
2,029
Disposals
(5,596)
(5,596)
At 28 February 2026
-
-
Net book value
At 28 February 2026
-
-
At 30 September 2024
9,546
9,546

5. Stocks and work in progress

28 Feb 2026
30 Sep 2024
£
£
Other stocks
-
1,011
Total
-
1,011

6. Debtors

28 Feb 2026
30 Sep 2024
£
£
Other debtors
2,185
-
Directors loan accounts
6,475
4,562
Prepayments and accrued income
-
2,167
Total due within one year
8,660
6,729
Total due after one year
-
-
Total
8,660
6,729

7. Creditors due within one year

28 Feb 2026
30 Sep 2024
£
£
Trade creditors
82
-
Taxation and social security
2,423
1,666
Accruals and deferred income
1,803
882
Total
4,308
2,548

8. Directors advances, credits and guarantees

Director
Brought forward
Amounts advanced
Amounts repaid
Carried forward
£
£
£
£
Summers, John Archbold
4,562
6,475
(4,562)
6,475
Total
4,562
6,475
(4,562)
6,475

The above loan is unsecured, interest free and repayable on demand.

9. Share capital

28 Feb 2026
30 Sep 2024
£
£
Allotted, called up and fully paid
Ordinary
1
1
Total
1
1